How to Trade This Cash-Rich Biopharma Name
This weekend’s covered call idea is around a cash-rich biopharma concern that is expecting a key FDA approval to close out 2026.
This weekend’s covered call idea is around a cash-rich biopharma concern that is expecting a key FDA approval to close out 2026.